These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1282818)

  • 1. Modulation of the rat mesolimbic dopamine pathway by neurokinins.
    Elliott PJ; Mason GS; Graham EA; Turpin MP; Hagan RM
    Behav Brain Res; 1992 Oct; 51(1):77-82. PubMed ID: 1282818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord.
    Cumberbatch MJ; Chizh BA; Headley PM
    Br J Pharmacol; 1995 Jul; 115(6):1005-12. PubMed ID: 7582496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins.
    Phenna S; Carpenter E; Peers C; Maudsley S; Gent JP
    Br J Pharmacol; 1996 Sep; 119(2):315-20. PubMed ID: 8886415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
    Hall JM; Morton IK
    Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
    Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
    Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat.
    Overton P; Elliott PJ; Hagan RM; Clark D
    Eur J Pharmacol; 1992 Mar; 213(1):165-6. PubMed ID: 1379929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL; van den Buuse M
    Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS; Zheng SZ; Feng MJ; Yan SE
    Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
    Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
    J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat.
    Lam FY; Wong MC
    Br J Pharmacol; 1996 Aug; 118(8):2107-14. PubMed ID: 8864549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
    Keegan KD; Woodruff GN; Pinnock RD
    Br J Pharmacol; 1992 Jan; 105(1):3-5. PubMed ID: 1375857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.